Chiari Type I Malformation Clinical Trial
Official title:
The Genetics of Chiari Type I Malformation (CMI) With or Without Syringomyelia
| NCT number | NCT01060800 |
| Other study ID # | Pro00011231 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | June 2009 |
| Est. completion date | April 25, 2017 |
| Verified date | March 2019 |
| Source | Duke University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Duke University Medical Center is investigating the hereditary basis of Chiari type I malformations with or without syringomyelia (CM1/S). Our research is aimed at learning if CM1/S is indeed caused by factors inherited through the family and, if so, which genes are involved.
| Status | Completed |
| Enrollment | 2000 |
| Est. completion date | April 25, 2017 |
| Est. primary completion date | April 25, 2017 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility | The study is not currently enrolling new participants. |
| Country | Name | City | State |
|---|---|---|---|
| United States | Duke University Medical Center | Durham | North Carolina |
| Lead Sponsor | Collaborator |
|---|---|
| Duke University |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Genetic factors contributing to Chiari Type I malformation | This study aims to identify genetic factors that contribute to or cause Chiari Type I malformation. | end of study |